2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$2.94+$0.09 (+3.02%)
Price as of Oct 02, 2026 6:33 PM EDT- $123.4MMarket Cap
- -14.41%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$2.94+$0.09 (+3.02%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.85 | ||
Change | -$0.07 (-2.40%) | ||
Open | $2.94 | ||
High | $3.00 | ||
Low | $2.83 | ||
Previous Close | $2.92 | ||
Volume | 625,975 | ||
30-Day Average Volume | 657,574 | ||
1-Week Change | -5.94% | ||
1-Month Change | -17.15% | ||
1-Year Change | -14.41% | ||
3-Year Change | 9.62% | ||
5-Year Change | -96.74% | ||
Fundamentals | |||
Shares Outstanding | 43.3M | ||
Total Assets | $34.2M | ||
Market Cap | $123.4M | ||
Enterprise Value | $97.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$16.5M | ||
Free Cash Flow | -$8.9M | ||
EBIT | -$16.5M | ||
EBITDA | -$16.4M | ||
Net Working Capital | -$4.7M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 88 | ||
P/B | -726 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue